Tag: Health Care

Displaying 1 - 20 of 1094 results.

Pages

Filtering by content type: Advocacy Filing

Filtering by content type: Press Release

Federal Trade Commission staff submitted written comments on the competitive impact of a legislative proposal to modify the supervision requirements imposed on advanced practice registered nurse-certified nurse practitioners (APRN-CNPs) in Pennsylvania.
Becton, Dickinson and Company and C. R. Bard, Inc. have agreed to divest two medical device product lines to settle Federal Trade Commission charges that Becton, Dickinson’s proposed $24 billion acquisition of Bard would negatively impact competition in those markets. Both companies supply a range...
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Integra LifeSciences Holdings Corp.’s $1 billion acquisition of Johnson & Johnson’s Codman Neuro division would negatively impact competition in those markets. Both companies supply...
The Federal Trade Commission has issued an administrative complaint challenging the merger of two prosthetics manufacturers that are top sellers of prosthetic knees equipped with microprocessors.
The Federal Trade Commission has approved an application by Fresenius Medical Care AG & Co. KGaA to establish a new outpatient hemodialysis clinic in Wyoming, Michigan at a location previously divested by Fresenius.
Federal Trade Commission Acting Bureau of Competition Director Bruce Hoffman issued the following statement regarding the U.S. District Court ruling yesterday that granted the request of the FTC and the Attorney General’s Office of North Dakota for a preliminary injunction in the proposed merger of...
The Federal Trade Commission will hold a public workshop in Washington, DC, on March 7, 2018 to explore issues regarding competition in the contact lens marketplace, consumer access to contact lenses, prescription release and portability, and related subjects. The workshop is being held in...
Following a public comment period, the Federal Trade Commission has approved a final order designed to remedy the anticompetitive effects resulting from Abbott’s $8.3 billion acquisition of Alere.

Filtering by content type: Case

Filtering by content type: Public Statement

Filtering by content type: Video

Filtering by content type: Advisory Opinion

Letter From Markus H. Meier, Assistant Director, Health Care Division, Bureau of Competition, to Jennifer R. Bolster, Esq., Hancock Estabrook, LLP, Concerning Crouse Health Hospital's Proposal To Sell Discounted Pharmaceutical Products to the Employees, Retirees, and Their Dependents...

Pages